Podlesak Dennis (CIK 1314595) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-06). Recent activity: Buy SNDX (48,000 shares), Buy SNDX (19,200 shares), Sell SNDX (19,200 shares), Buy SNDX (19,200 shares), Sell SNDX (19,200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Director | Buy | 48,000 | $0 |
| 2025-08-18 | Syndax Pharmaceuticals Inc (SNDX) | Director | Buy | 19,200 | $138,240 |
| 2025-08-18 | Syndax Pharmaceuticals Inc (SNDX) | Director | Sell | 19,200 | $272,448 |
| 2025-08-18 | Syndax Pharmaceuticals Inc (SNDX) | Director | Buy | 19,200 | $138,240 |
| 2025-08-18 | Syndax Pharmaceuticals Inc (SNDX) | Director | Sell | 19,200 | $298,368 |
| 2025-08-18 | Syndax Pharmaceuticals Inc (SNDX) | Director | Buy | 19,200 | $138,240 |
| 2025-08-18 | Syndax Pharmaceuticals Inc (SNDX) | Director | Sell | 19,200 | $304,128 |
Source: SEC Form 4 filings · as of 2026-02-06